Hind Rafei
@hindrafei.bsky.social
Physician-scientist at MD Anderson Cancer Center investigating cellular immunotherapy for solid cancers with a focus on the solid TME. Opinions are my own.
ICYMI: A guide to CAR T cell therapies: development, current status and future prospects
A guide to CAR T cell therapies: development, current status and future prospects
Nature Reviews Immunology, Published online: 02 July 2026; doi:10.1038/s41577-026-01322-1This Review traces the development of chimeric antigen receptor (CAR) T cell therapy from foundational immunology to approved products, highlighting clinical successes, engineering advances, safety strategies and ongoing challenges in extending durable responses beyond haematological malignancies.
dlvr.it
NEW Review: A guide to CAR T cell therapies by @hindrafei.bsky.social, Ranjan Upadhyay & @pamsharmamdphd.bsky.social @mdanderson.bsky.social traces the development of CAR T cells from foundational discoveries to approved products www.nature.com/articles/s41...
Review @natrevimmunol.nature.com @hindrafei.bsky.social A guide to CAR T cell therapies: development, current status and future prospects www.nature.com/articles/s41...
A guide to CAR T cell therapies: development, current status and future prospects
A guide to CAR T cell therapies: development, current status and future prospects
Nature Reviews Immunology, Published online: 02 July 2026; doi:10.1038/s41577-026-01322-1This Review traces the development of chimeric antigen receptor (CAR) T cell therapy from foundational immunology to approved products, highlighting clinical successes, engineering advances, safety strategies and ongoing challenges in extending durable responses beyond haematological malignancies.
dlvr.it
I am very excited to be attending #ASGCT2026 where I will be chairing a session on novel myeloid and T cell strategies for cellular therapies on Tuesday. Please reach out or come say hi if you are around and would like to meet and chat @utmdanderson.bsky.social @asgct.bsky.social #cellTx #CAR
Programme at a glance
pag.virtual-meeting.org
Thanks DoD Ovarian Cancer Research Program for Support - Hind Rafei (@hindrafei.bsky.social) @mdanderson.bsky.social oncodaily.com/voices/hind-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Hind Rafei: Thanks DoD Ovarian Cancer Research Program for Support - OncoDaily
Hind Rafei: Thanks DoD Ovarian Cancer Research Program for Support / cancer, Hind Rafei, MD Anderson Cancer Center, OncoDaily, Oncology
oncodaily.com
Registration for the GRC in Single-cell cancer biology is now open! The meeting features sessions on emergent topics such as Spatial Technologies, AI, Tumor Immune Response and Resistance, and many more. Do not miss a stellar line-up of speakers & leaders in the field! www.grc.org/single-cell-...
Congratulations to the 2025 Sabin Family Fellowship recipients, 10 early career researchers recognized for their bold, high-impact cancer research. Thank you to the Sabin Family Fellowship for supporting the next generation of innovators. http://spr.ly/633254IbgR #EndCancer
MD Anderson announces 10th cohort of Andrew Sabin Family Fellows
The University of Texas MD Anderson Cancer Center today announced its 10th cohort of Andrew Sabin Family Fellows, comprised of 10 early career cancer researchers. Created to provide a dedicated source of funding for emerging clinician and scientist leaders, the Sabin Family Fellowship supports groundbreaking research that fuels MD Anderson’s mission to end cancer.
spr.ly
Don't miss this killer episode! Dr. Rizwan Romee talks about #NaturalKiller cells and how they can be engineered to target cancers. Check it out: bit.ly/3I19hq6
Nature research paper: CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells https://go.nature.com/4mNx4tJ
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells - Nature
The transcription factor CREM is a pivotal regulator of NK cell function, making CREM a valuable target to increase the efficacy of anticancer immunotherapies based on this cell population and chimeric antigen receptors.
go.nature.com
I’m thrilled to share our work out now in Nature identifying CREM as a central intracellular checkpoin in #CARNK cells. 📄Link: nature.com/articles/s41... Our story👇🏼
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells - Nature
The transcription factor CREM is a pivotal regulator of NK cell function, making CREM a valuable target to increase the efficacy of anticancer immunotherapies based on this cell population and chimeri...
nature.com